Description
A nuclesoside analog that disrupts DNA synthesis in blood cells; effective in a number of animal tumor systems including LI210 leukemia, CD8F mammary adenocarcinoma, P388 leukemia, and human LX-1 lung tumor xenograft and displays anticancer activity against human hematological malignancies in vivo
Formal name: 9-β-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine
Synonyms: F-ara-A|NSC 118218
Molecular weight: 285.2
CAS: 21679-14-1
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Nucleotides/Nucleosides||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cancer|Cell Death|Apoptosis